Korea Bio-Gen Co.Ltd (318000) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Korea Bio-Gen Co.Ltd (318000) has a cash flow conversion efficiency ratio of 0.032x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.51 Billion ≈ $1.02 Million USD) by net assets (₩46.98 Billion ≈ $31.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Korea Bio-Gen Co.Ltd for the company's overall valuation and market capitalisation.
Korea Bio-Gen Co.Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Korea Bio-Gen Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Korea Bio-Gen Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Korea Bio-Gen Co.Ltd ranked by their cash flow conversion efficiency. Explore 318000 cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ZOONO Group Ltd
AU:ZNO
|
-0.356x |
|
BIORETEC OY
F:0TN
|
N/A |
|
Huddlestock Fintech As
OL:HUDL
|
-0.273x |
|
Priceworth International Bhd
KLSE:7123
|
-0.039x |
|
Arcure SA
PA:ALCUR
|
0.282x |
|
Inno Holdings Inc. Common Stock
NASDAQ:INHD
|
-0.063x |
|
Builders Capital Mortgage Corp
V:BCF
|
N/A |
|
HM Inwest S.A.
WAR:HMI
|
0.164x |
Annual Cash Flow Conversion Efficiency for Korea Bio-Gen Co.Ltd (2017–2025)
The table below shows the annual cash flow conversion efficiency of Korea Bio-Gen Co.Ltd from 2017 to 2025. View 318000 live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩46.93 Billion ≈ $31.80 Million |
₩7.34 Billion ≈ $4.97 Million |
0.156x | +63.74% |
| 2024-12-31 | ₩44.91 Billion ≈ $30.44 Million |
₩4.29 Billion ≈ $2.91 Million |
0.096x | -57.57% |
| 2023-12-31 | ₩42.05 Billion ≈ $28.50 Million |
₩9.47 Billion ≈ $6.42 Million |
0.225x | +371.25% |
| 2022-12-31 | ₩34.95 Billion ≈ $23.68 Million |
₩1.67 Billion ≈ $1.13 Million |
0.048x | -51.19% |
| 2021-12-31 | ₩31.61 Billion ≈ $21.42 Million |
₩3.09 Billion ≈ $2.10 Million |
0.098x | +6.83% |
| 2020-12-31 | ₩28.16 Billion ≈ $19.09 Million |
₩2.58 Billion ≈ $1.75 Million |
0.092x | -22.91% |
| 2019-12-31 | ₩25.69 Billion ≈ $17.41 Million |
₩3.05 Billion ≈ $2.07 Million |
0.119x | -34.28% |
| 2018-12-31 | ₩10.97 Billion ≈ $7.44 Million |
₩1.98 Billion ≈ $1.34 Million |
0.181x | +16.60% |
| 2017-12-31 | ₩8.93 Billion ≈ $6.05 Million |
₩1.38 Billion ≈ $938.31K |
0.155x | -- |
About Korea Bio-Gen Co.Ltd
KBG Corp. produces and supplies a range of fine chemicals in South Korea and internationally. The company offers silicone chemicals, such as functional organosilanes, functional silicone polymers, silicone resins and intermediates, silicone pressure sensitive adhesives, and silicone materials for electronics; specialty chemicals, including polymerization inhibitors; and food additives, as well as… Read more